German biotech player Miltenyi Biotec announced the rollout of its India operations with the opening of its first office in Hyderabad and unveiled plans to set up the Miltenyi Innovation & Technology Centre that will serve as a centre of excellence (CoE) for cell & gene therapy (CGT), at Hyderabad.
Miltenyi Biotec opens its first office in Hyderabad; Plans to invest in gene therapy financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
The cell and gene therapy Centre of Excellence will be among the first of its kind in India, providing cutting-edge training, research, expertise, and manufacturing solutions
Miltenyi Biotec to open Cell and Gene Therapy Centre of Excellence in Hyderabad biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
German biomedical discovery provider Miltenyi Biotec is launching operations in India, opening its first office and setting up a Centre of Excellence. The CoE will offer training in cell and gene therapy and contribute to the vibrant life sciences ecosystem by supporting local development and manufacturing in India.
Miltenyi Biotec To Set Up Innovation And Technology Center In Hyderabad menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Miltenyi Biotec, a global biotechnology company, will launch its operations in India with the setting up of Innovation and Technology Center in Hyderabad.This Centre of Excellence (COE) will be one of its first of its kind in India where .
German firm Miltenyi Biotec opens office, plans Cell and Gene Therapy CoE thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell.
Exyte Empowers the Biopharmaceutical Industry: First ExyCell Facility Launched in Shanghai finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.